Special Issue "Cisplatin in Cancer Therapy: Molecular Mechanisms of Action 3.0"

被引:20
作者
Gandin, Valentina [1 ]
Hoeschele, James D. [2 ]
Margiotta, Nicola [3 ]
机构
[1] Univ Padua, Dept Pharmaceut & Pharmacol Sci, I-35131 Padua, Italy
[2] Eastern Michigan Univ, Dept Chem, Ypsilanti, MI 48197 USA
[3] Univ Bari Aldo Moro, Dipartimento Chim, I-70125 Bari, Italy
关键词
PRODRUG;
D O I
10.3390/ijms24097917
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页数:5
相关论文
共 16 条
[1]   A chemical perspective on the clinical use of platinum-based anticancer drugs [J].
Alassadi, Shoohb ;
Pisani, Michelle J. ;
Wheate, Nial J. .
DALTON TRANSACTIONS, 2022, 51 (29) :10835-10846
[2]   Can Cisplatin Therapy Be Improved? Pathways That Can Be Targeted [J].
Ali, Reem ;
Aouida, Mustapha ;
Sulaiman, Abdallah Alhaj ;
Madhusudan, Srinivasan ;
Ramotar, Dindial .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (13)
[3]   Improvement of Kiteplatin Efficacy by a Benzoato Pt(IV) Prodrug Suitable for Oral Administration [J].
Barbanente, Alessandra ;
Gandin, Valentina ;
Ceresa, Cecilia ;
Marzano, Cristina ;
Ditaranto, Nicoletta ;
Hoeschele, James D. ;
Natile, Giovanni ;
Arnesano, Fabio ;
Pacifico, Concetta ;
Intini, Francesco P. ;
Margiotta, Nicola .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (13)
[4]   Synthesis, characterization, and in vitro cytotoxicity of a Kiteplatin-Ibuprofen Pt(IV) prodrug [J].
Curci, Alessandra ;
Denora, Nunzio ;
Iacobazzi, Rosa Maria ;
Ditaranto, Nicoletta ;
Hoeschele, James D. ;
Margiotta, Nicola ;
Natile, Giovanni .
INORGANICA CHIMICA ACTA, 2018, 472 :221-228
[5]   The Rationale for "Laser-Induced Thermal Therapy (LITT) and Intratumoral Cisplatin" Approach for Cancer Treatment [J].
de Brito, Renan Vieira ;
Mancini, Marilia Wellichan ;
Palumbo, Marcel das Neves ;
Oliveira de Moraes, Luis Henrique ;
Rodrigues, Gerson Jhonatan ;
Cervantes, Onivaldo ;
Sercarz, Joel Avram ;
Paiva, Marcos Bandiera .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (11)
[6]   New Synthetic Lethality Re-Sensitizing Platinum-Refractory Cancer Cells to Cisplatin In Vitro: The Rationale to Co-Use PARP and ATM Inhibitors [J].
Folk, Watson P. ;
Kumari, Alpana ;
Iwasaki, Tetsushi ;
Cassimere, Erica K. ;
Pyndiah, Slovenie ;
Martin, Elizabeth ;
Homlar, Kelly ;
Sakamuro, Daitoku .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (24)
[7]   trans,cis,cis-Bis(benzoato)dichlorido(cyclohexane-1R,2R-diamine)platinum(IV): a Prodrug Candidate for the Treatment of Oxaliplatin-Refractory Colorectal Cancer [J].
Gandin, Valentina ;
Marzano, Cristina ;
Pelosi, Giorgio ;
Ravera, Mauro ;
Gabano, Elisabetta ;
Osella, Domenico .
CHEMMEDCHEM, 2014, 9 (06) :1299-1305
[8]   Platinum(IV) anticancer prodrugs - hypotheses and facts [J].
Gibson, Dan .
DALTON TRANSACTIONS, 2016, 45 (33) :12983-12991
[9]   Genomic Characterization of Cisplatin Response Uncovers Priming of Cisplatin-Induced Genes in a Resistant Cell Line [J].
Golan Berman, Hadar ;
Chauhan, Pooja ;
Shalev, Shira ;
Hassanain, Hiba ;
Parnas, Avital ;
Adar, Sheera .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (11)
[10]   Antagonistic Interaction between Histone Deacetylase Inhibitor: Cambinol and Cisplatin-An Isobolographic Analysis in Breast Cancer In Vitro Models [J].
Halasa, Marta ;
Luszczki, Jarogniew J. ;
Dmoszynska-Graniczka, Magdalena ;
Baran, Marzena ;
Okon, Estera ;
Stepulak, Andrzej ;
Wawruszak, Anna .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (16)